The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“Interestingly, antidepressants have been shown to produce the same increase in those growth factors but only after 2 to 3 weeks (Nibuya et al., 1995; Duman et al., 1997).”
BackgroundBaclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release
Xi, Z.-X., & Stein, E. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35044-x · Cited by 177 · cited 1×
“The importance of these observations in the possible treatment of drug abuse is reinforced by the finding that baclofen reduces craving for a host of addictive substances, including heroin, alcohol, and nicotine (Xi and Stein, 1999; Corrigall et al., 2000; Lobina et al., 2000).”
BackgroundSloviter, R. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00132-x · Cited by 86
Cited by
Olsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors
Pin, J.-P., Galvez, T., & Prézeau, L. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00038-x · Cited by 662
Identified sources and targets of slow inhibition in the neocortex
Tamás, G., Simon, A. L., & Szabadics, J. (2003) · Science · doi:10.1126/science.1082053 · Cited by 359
Toward a Biosignature for Suicide
Oquendo, M. A., Sullivan, G. M., Sudol, K., Baca-Garcia, E., Stanley, B. H., Sublette, M. E., & Mann, J. J. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020194 · Cited by 299
The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294
Kruglikov, I., & Rudy, B. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.024 · Cited by 209
A gut feeling about GABA: focus on GABAB receptors.
Hyland, N. P., & Cryan, J. F. (2010) · Frontiers in Pharmacology · doi:10.3389/fphar.2010.00124 · Cited by 199
Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Braun, M., Wendt, A., Buschard, K., Salehi, A., Sewing, S., Gromada, J., & Rorsman, P. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066563 · Cited by 80
Gassmann, M., Haller, C., Stoll, Y., Aziz, S. A., Biermann, B., Mosbacher, J., Kaupmann, K., & Bettler, B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010256 · Cited by 56
Self-citationTakahashi, A., Kwa, C., DeBold, J. F., & Miczek, K. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1920-x · Cited by 52
Murai, N., Kondo, Y., Akuzawa, S., Mihara, T., Shiraishi, N., Kakimoto, S., & Matsumoto, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172750 · Cited by 34
Foster, J. D., Kitchen, I., Bettler, B., & Chen, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12073 · Cited by 33
Self-citationVavers, E., Zvejniece, L., & Dambrova, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106771 · Cited by 30
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
Walzer, M., Marek, G. J., Wu, R., Nagata, M., & Han, D. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.766 · Cited by 19
Effects of GABAB receptor agonists and antagonists on glycemia regulation in mice
Bonaventura, M. M., Crivello, M., Ferreira, M. L., Repetto, M., Cymeryng, C., Libertun, C., & Lux-Lantos, V. A. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.013 · Cited by 19
GABAB receptor subunit 1 binds to proteins affected in 22q11 deletion syndrome
Zunner, D., Deschermeier, C., & Kornau, H.-C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.120 · Cited by 11
Metadata
- Authors
- Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F., Raiteri, M., Bonner, T. I., & Enna, S. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 54
- Issue
- 2
- Pages
- 247-264
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2157230965
- Cited by
- 601
- References
- 5
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
